Search results
Photocure Partner Asieris announces New Drug Application acceptance for regulatory review of Cevira...
FOX 59 Indianapolis· 8 hours agoPhotocure ASA (OSE: PHO), the Bladder Cancer Company, announces that its partner Asieris...
Billionaire Jim Simons Owns These 2 Healthcare Stocks: Should You?
Motley Fool via Yahoo Finance· 3 minutes agoIts two most important markets are renal cell carcinoma (RCC, a type of kidney cancer) and...
Experimental cancer treatment gives New Jersey mom a chance for a second baby: ‘I decided to go for...
Fox News· 9 hours agoA New Jersey mom had just given birth when she received a life-changing cancer diagnosis — and her...
UC San Diego's New AI Platform Accelerates Cancer Drug Development
Gadgets 360· 4 days agoUC San Diego scientists have made a breakthrough in cancer drug development with a groundbreaking AI...
Report: State employees health care plan for drugs being overcharged
The Center Square· 5 hours agoNonprofit hospitals can receive deep discounts from pharmaceutical companies for drugs under a...
BioAtla gets FDA nod for new cancer drug trial By Investing.com
Investing.com· 6 days agoFood and Drug Administration (FDA) has approved its investigational new drug (IND) application. This...
A New Drug Is Helping Cervical Cancer Patients Live Longer
Verywell Health via Yahoo News· 4 days agoIllustration by Zoe Hansen for Verywell Health Fact checked by Nick Blackmer Key Takeaways The FDA...
Simulated chemistry: New AI platform designs tomorrow's cancer drugs
Phys.org· 6 days agoThe researchers used the new tool, described in Nature Communications, to synthesize 32 new drug candidates for cancer
"Magic Pill" Author Johann Hari Shares Investigation Into Weight Loss Drugs
KATU Portland· 2 days agoJohann Hari, author of the new book "Magic Pill: The Extraordinary Benefits and Disturbing Risks of...
An Innovative New Cancer Treatment – Scientists Unveil Nanoparticle Capable of Crossing Blood-Brain...
SciTechDaily· 8 hours agoThe scientists are optimistic that their method, which has shown initial promise in preclinical...